文献速递主动脉外科

NAVIGATE登记研究:Nexus升主动脉模块早期腔内修复升主动脉病变

The NAVIGATE Registry: Early Endovascular Repair of the Ascending Aorta With the Nexus Ascending Module.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2026-01-01

NAVIGATE为欧洲多中心回顾性登记研究,纳入8例不适合开放手术的高危升主动脉0区病变患者,使用CE认证的Nexus升主动脉模块行经股动脉腔内修复。中位随访15个月无主动脉再干预或器械相关并发症,结论为技术可行但属初步假设生成性发现。

要点

  • 无卒中、瓣膜功能障碍、冠脉受累、心包填塞、I/III型内漏或30天死亡
  • 中位随访15个月无主动脉再干预或器械相关并发症

核心结论

  • Nexus升主动脉模块对高度选择的孤立性0区升主动脉病变行腔内修复技术可行,但属初步假设生成性发现。

研究设计与样本

  • NAVIGATE为欧洲回顾性多中心登记研究,2023至2025年间在6家三级中心纳入8例高危患者。
  • 所有患者均为局限性0区病变且被判定不适合开放手术,术前采用ECG门控CT血管造影规划,经股动脉入路操作。

主要发现

  • 中位年龄80.0岁(IQR:59.5-80.5),87.5%有既往心脏手术史,中位EuroSCORE II为24.0%(IQR:19.7%-44.0%)。
  • 病变包括包裹性破裂/假性动脉瘤4例、真菌性假性动脉瘤3例、DeBakey II型A型夹层1例。
  • 技术成功全部实现,其中2例需即刻重叠支架移植物以完全封堵。
  • 无卒中、瓣膜功能障碍、冠状动脉受累、心包填塞、I/III型内漏、中转手术或院内/30天死亡,观察到1例入路相关并发症。
  • 中位ICU和住院时间分别为1天和5天;中位随访15个月(IQR:12-24)无主动脉再干预或器械相关并发症,2例分别于12个月和4个月死于呼吸系统疾病和持续感染。

临床怎么用

  • 对于不适合开放手术的高度选择孤立性0区升主动脉病变患者,可考虑Nexus升主动脉模块腔内修复作为探索性选择。

局限性

  • 样本量小(8例),为回顾性多中心病例系列,结果属初步且需假设生成性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Open repair remains the standard for ascending aortic pathology but carries high morbidity in frail or inoperable patients. This study evaluates the feasibility and early outcomes of endovascular repair using the Nexus Ascending Module, a CE-marked device designed for zone 0. METHODS: NAVIGATE is a retrospective multicentre European registry including 8 high-risk patients treated between 2023 and 2025 across 6 tertiary centres. All had focal zone 0 pathology and were deemed unsuitable for open repair. Procedures were planned with ECG-gated CT angiography and performed transfemorally. Technical success, perioperative complications, 30-day mortality, and follow-up outcomes were assessed. RESULTS: Median age was 80.0 years (IQR: 59.5-80.5), and 87.5% had prior cardiac surgery. The median EuroSCORE II was 24.0% (IQR: 19.7%-44.0%). Pathologies included contained rupture/pseudoaneurysm (n = 4), mycotic pseudoaneurysm (n = 3), and type A DeBakey II dissection (n = 1). Technical success was achieved in all patients; 2 required immediate overlapping stent-grafts for complete sealing. No stroke, valve dysfunction, coronary compromise, tamponade, type I/III endoleak, conversion to surgery, or in-hospital/30-day mortality occurred. One access-related complication was observed.Median ICU and hospital stays were 1 and 5 days. At a median follow-up of 15 months (IQR: 12-24), no aortic reinterventions or device-related complications occurred. Two patients died from respiratory disease (12 months) and persistent infection (4 months). CONCLUSIONS: This small multicentre case series suggests that endovascular repair of isolated zone 0 ascending pathology using the Nexus Ascending Module is technically feasible in highly selected patients; however, these findings are preliminary and hypothesis-generating.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Mosquera VX, Ferreiro A, Abisi S, et al. The NAVIGATE Registry: Early Endovascular Repair of the Ascending Aorta With the Nexus Ascending Module. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 42063219. doi:10.1093/icvts/ivag128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。